Similar articles

• Genetic control of hepatocarcinogenesis in C3H mice.

  Drinkwater NR. Drinkwater NR. Drug Metab Rev. 1994;26(1-2):201-8. doi: 10.3109/03602539409029791. Drug Metab Rev. 1994. PMID: 8082565 Review. No abstract available.
• Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice.

  Manenti G, Binelli G, Gariboldi M, Canzian F, De Gregorio L, Falvella FS, Dragani TA, Pierotti MA. Manenti G, et al. Genomics. 1994 Sep 1;23(1):118-24. doi: 10.1006/geno.1994.1466. Genomics. 1994. PMID: 7829059
• Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver.

  Vorce RL, Goodman JI. Vorce RL, et al. J Toxicol Environ Health. 1991 Nov;34(3):385-95. doi: 10.1080/15287399109531575. J Toxicol Environ Health. 1991. PMID: 1942124
• High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.

  Iwai S, Murai T, Makino S, Min W, Morimura K, Mori S, Hagihara A, Seki S, Fukushima S. Iwai S, et al. Cancer Lett. 2007 Feb 8;246(1-2):115-21. doi: 10.1016/j.canlet.2006.02.008. Epub 2006 Mar 29. Cancer Lett. 2007. PMID: 16569478
• Genetic analysis of multistage hepatocarcinogenesis.

  Poole TM, Chiaverotti TA, Carabeo RA, Drinkwater NR. Poole TM, et al. Prog Clin Biol Res. 1996;395:33-45. Prog Clin Biol Res. 1996. PMID: 8895982 Review. No abstract available.